Morgan Stanley’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.47M | Sell |
|
|||||
|
2025
Q1 | $7.74M | Buy |
|
|||||
|
2024
Q4 | $8.72M | Buy |
|
|||||
|
2024
Q3 | $2M | Buy |
|
|||||
|
2024
Q2 | $378K | Sell |
|
|||||
|
2024
Q1 | $758K | Buy |
|
|||||
|
2023
Q4 | $466K | Buy |
|
|||||
|
2023
Q3 | $146K | Sell |
|
|||||
|
2023
Q2 | $254K | Buy |
|
|||||
|
2023
Q1 | $181K | Buy |
|
|||||
|
2022
Q4 | $165K | Buy |
|
|||||
|
2022
Q3 | $238K | Buy |
|
|||||
|
2022
Q2 | $132K | Buy |
|
|||||
|
2022
Q1 | $116K | Buy |
|
|||||
|
2021
Q4 | $98K | Sell |
|
|||||
|
2021
Q3 | $204K | Buy |
|
|||||
|
2021
Q2 | $228K | Buy |
|
|||||
|
2021
Q1 | $143K | Sell |
|
|||||
|
2020
Q4 | $191K | Buy |
|
|||||
|
2020
Q3 | $235K | Buy |
|
|||||
|
2020
Q2 | $163K | Buy |
|
|||||
|
2020
Q1 | $2K | Hold |
|
|||||
|
2019
Q4 | $2K | Sell |
|
|||||
|
2019
Q3 | $13K | Buy |
|
|||||
|
2019
Q2 | $0 | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $20K | Hold |
|
|||||
|
2017
Q1 | $81K | Sell |
|
|||||
|
2016
Q4 | $104K | Sell |
|
|||||
|
2016
Q3 | $135K | Sell |
|
|||||
|
2016
Q2 | $165K | Sell |
|
|||||
|
2016
Q1 | $106K | Sell |
|
|||||
|
2015
Q4 | $173K | Buy |
|
|||||
|
2015
Q3 | $169K | Buy |
|
|||||
|
2015
Q2 | $184K | Buy |
|
|||||
|
2015
Q1 | $249K | Buy |
|